about
Salinomycin as a drug for targeting human cancer stem cellsSalinomycin: a novel anti-cancer agent with known anti-coccidial activitiesInhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell linesSensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3β, pTSC2, and p4EBP1 by cotreatment with MK-2206.Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cellsMulti-targeted therapy of cancer by niclosamide: A new application for an old drug.Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitroSalinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells.Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 proteinGenetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetesSalinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells.Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.Discovery of a (19)F MRI sensitive salinomycin derivative with high cytotoxicity towards cancer cells.Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.Lower salinomycin concentration increases apoptotic detachment in high-density cancer cells.An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cellsInhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenanceSalinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.The effect of salinomycin on ovarian cancer stem-like cells.Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy.Low amount of salinomycin greatly increases Akt activation, but reduces activated p70S6K levelsEffects of salinomycin and 17‑AAG on proliferation of human gastric cancer cells in vitro.Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.Structures and properties of naturally occurring polyether antibiotics.Trypanocidal activity of salinomycin is due to sodium influx followed by cell swellingSalinomycin effects on mitochondrial ion translocation and respiration.P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin.Rumen microbial changes in cattle fed diets with or without salinomycin.Direct cloning and heterologous expression of the salinomycin biosynthetic gene cluster from Streptomyces albus DSM41398 in Streptomyces coelicolor A3(2).Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesXylanilyticolides A-C, Three New Compounds from Cultures of the Actinomycete Promicromonospora xylanilytica YIM 61515.Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.
P2860
Q21285139-668F9DB8-EBD9-47DB-BD32-AA07D6626EADQ26853644-EB1C8CAF-E2AF-44CA-A1BC-50B687B7D20AQ28534136-9B120F95-6965-472F-A069-79B44B8420EDQ28537942-CCE3B551-D1C0-48B7-B431-AD4A1ED00EBFQ33992871-D9492FB9-D2D7-4581-90D6-B19CC031B93CQ34052780-32B4081B-DE44-4BF8-A279-0993A10E0E1DQ34199032-86739EF4-1E32-4F6F-9F70-BB3A987EE4CBQ34443640-FB88ABA0-E0EF-4FD7-8FE2-26468E623F2DQ34531550-C8EC31C2-3F3F-4509-86AC-95A7835215AEQ34577035-2BA38B04-67C8-40F1-9867-61B6BBD1D198Q34583585-750D2287-665D-4A69-BBD4-3CFBAEF57191Q35077331-37CDCF1A-B46D-406F-9865-509C672D3BA6Q35111314-B879BAE0-EC7D-413D-AE8D-A7B015767376Q35164584-8FF225BE-0E57-4A74-B0BA-2531C80B9565Q35653860-5A748651-776A-4569-85FE-60F9FE30C123Q35964323-B01CE761-EB9B-4BF6-B4D4-01C14186B527Q36104984-161D7396-59F7-40B6-93B5-44AF9DDC8A1CQ36396532-D1249D2C-E310-4CA4-8E6E-E5ACBCF0CFCCQ36408904-AA16FADF-C1ED-4FBB-AEB2-75BD8A043B27Q36892078-F1E317DD-B61B-4457-9FF0-A1248EE33A64Q36985137-48BDFA91-DE05-434D-946C-74FDBEE3C979Q37121113-F6AB1543-1A27-48FB-9A25-60D34A7ABC23Q37158877-C552596A-20D2-499C-B3F4-9D9D9941E59CQ37225029-439AD649-8AC0-4349-8C8D-7388C0F371EDQ38699905-DC4B3B9E-DAAA-4A7C-B1AE-69991124A9D9Q38709612-A5743B57-9FF4-4839-9A27-68064EDEAC14Q39469088-76588C0A-48A8-4F5E-9172-62F2D72FC6DEQ39724954-C447B8F7-E293-4261-AF1B-432C14A05C9EQ39768003-492F2A2A-770C-4771-968D-3A31664BD570Q40025134-5730A977-CCF7-4EB1-9F55-238A51B141CDQ40052885-0E2B2E1D-4AD9-4B51-91F8-2EA7885907B9Q40955994-34B51904-7C28-4793-ADD0-FF17BAD14A69Q41664067-9F53DD65-6AD8-43F5-BDAE-15BFA92943FAQ50021032-6F54FCD4-C4B7-4C34-A6E9-D3851B27BCB2Q50057844-D9C84CAC-9408-41A7-8F19-95D0A1C5C585
P2860
description
1974 nî lūn-bûn
@nan
1974 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Salinomycin, a new polyether antibiotic.
@ast
Salinomycin, a new polyether antibiotic.
@en
Salinomycin, a new polyether antibiotic.
@nl
type
label
Salinomycin, a new polyether antibiotic.
@ast
Salinomycin, a new polyether antibiotic.
@en
Salinomycin, a new polyether antibiotic.
@nl
prefLabel
Salinomycin, a new polyether antibiotic.
@ast
Salinomycin, a new polyether antibiotic.
@en
Salinomycin, a new polyether antibiotic.
@nl
P2093
P1476
Salinomycin, a new polyether antibiotic
@en
P2093
P304
P356
10.7164/ANTIBIOTICS.27.814
P577
1974-11-01T00:00:00Z